semaglutide death Study finds reduces CKD progression and CV risk in patients with diabetes and CKD Semaglutide cuts risk for worsening

Wachter S, Vogt M, et al

A personalized nutrition strategy designed around your medication's mechanismnot generic diet advicecompounds your therapy's effectiveness

Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptorexpressing glutamatergic neurons

(2026) frame their discussion around the question of whether acquired oral pigmentation represents "a benign finding or a malignant clue." Oral melanoma is rare, but it is aggressive when it occurs, which is precisely why any new, changing, or unusual pigmented lesion in the mouth warrants clinical evaluation rather than watchful waiting at home

In placebo-controlled trials, patients treated with this drug had a mean increase from baseline in amylase of up to 16% and lipase of up to 39%